TERN
Terns Pharmaceuticals, Inc. · Healthcare
Orbimed Advisors LLC bought $8.9M of Terns Pharmaceuticals, Inc.
Director and 10% owner
Bought$8,929,800
$2.42Price
3,690,000Shares
−126%Stake
What TERN did for a copier
- $1,000 copied at Fri, Aug 19 open, $4.61
- $1,377
- S&P 500, same days
- −13.4%
Measured over 30 trading days, to the Oct 3 close.
Orbimed Advisors LLC's record
34 other buys with 3 months of prices since 2016: on average −13.2% against the S&P 500, and 11 of 34 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Aug 16. Filed Thu, Aug 18, 5:00 PM ET, after the close. Returns use the Aug 19 open and the Oct 3 close. Not investment advice.